The influence of HBsAg expression in liver tissue on the postoperative recurrence of HCC patients.
10.3760/cma.j.cn112152-20200823-00762
- Author:
Qiao Mei LI
1
;
Hua Bang ZHOU
2
;
He Ping HU
2
;
Yuan HUANG
3
;
Huan ZHAO
3
;
Shang Wen YANG
1
Author Information
1. Department of Gastroenterology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
2. Department of Hepatobiliary, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
3. Department of Pathology, Lishui Central Hospital, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
- Publication Type:Journal Article
- Keywords:
Hepatitis B surface antigen;
Hepatocellular neoplasms;
Peritumoral tissue;
Recurrence
- MeSH:
Carcinoma, Hepatocellular/pathology*;
China;
DNA, Viral/analysis*;
Hepatitis B Surface Antigens;
Hepatitis B virus/metabolism*;
Humans;
Liver Neoplasms/pathology*
- From:
Chinese Journal of Oncology
2022;44(4):347-353
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the influence of HBsAg expression in peritumoral tissue of hepatocellular carcinoma (HCC) patients on their postoperative recurrence. Methods: The HCC patients treated in Shanghai Eastern Hepatobiliary Surgery Hospital from October 2009 to August 2010 were selected. The clinicopathological data and adjacent tissues of 718 patients were collected, and dextran polymer immunohistochemical staining was used to detect the expression of HBsAg in adjacent tissues. According to the expression of HBsAg in adjacent tissues, the tissues were divided into HBsAg positive group and HBsAg negative group. Kaplan-Meier method and Log rank test were used for survival analysis, and Cox regression model was used for multivariate analysis. Results: Among the 718 patients in the whole group, 153 were HBsAg negative and 565 were HBsAg positive. There was a statistically significant difference in serum HBV DNA level between HBsAg-positive and HBsAg-negative patients (P<0.001). The number of patients with serum DNA≥2 000 IU/ml and<2 000 IU/ml in HBsAg negative group were 52 and 93, while the patients in HBsAg positive group were 325 and 205. The cumulative recurrence rates of all patients at 1, 3, and 5 years after surgery were 30.2%, 54.3%, and 62.7%, respectively. The expression of HBsAg was related to the recurrence (P=0.038). Multivariate analysis showed that γ-GT, PT, multiple tumors, tumor length, and portal vein invasion were independent risk factors for recurrence of HCC (P<0.05). In HBeAg-negative patients with low viral load (HBV DNA <2 000 IU/ml) and without cirrhosis, the recurrence rates of HBsAg-positive patients were 14.3% and 31.0% at 3 and 5 years, respectively, compared with HBsAg negative patients (all 0), the difference was statistically significant (P=0.021). Conclusion: The positive expression of HBsAg in peritumoral tissue increases the postoperative recurrence risk of HCC patients.
